Time-varying exposure to anti-osteoporosis drugs and risk of first-time hip fracture: a population wide study within the Norwegian Epidemiologic Osteoporosis Studies (NOREPOS)

SUMMARY: We investigated the association between bisphosphonate and denosumab use and risk of hip fracture in Norway. These drugs protect against fractures in clinical trials, but their population-level effect is unknown. Our results showed lowered risk of hip fracture for treated women. Treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Riska, Brit Solvor Lyse, Gunnes, Nina, Stigum, Hein, Finnes, Trine E., Meyer, Haakon E., Omsland, Tone K., Holvik, Kristin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382386/
https://www.ncbi.nlm.nih.gov/pubmed/37100950
http://dx.doi.org/10.1007/s00198-023-06752-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382386/
https://www.ncbi.nlm.nih.gov/pubmed/37100950
http://dx.doi.org/10.1007/s00198-023-06752-4

Ejemplares similares